Incidence, Risk Factors, and Outcomes of Transition of HIPEC- Induced Acute Kidney Injury to Acute Kidney Disease: A Retrospective Study

Yunwei Lu,Xiujuan Zhao,Yingjiang Ye,Shu Li,Fuzheng Guo,Haiyan Xue,Fengxue Zhu

DOI: https://doi.org/10.21203/rs.3.rs-1820140/v1

2022-01-01

Abstract:Abstract Background: Cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) has benefited selected patients with peritoneal malignancies. Acute kidney injury (AKI) is recognized as a common complication following the CRS-HIPEC procedure. Characterized with prolonged renal function impairment, acute kidney disease (AKD) is associated with a higher risk of chronic kidney disease (CKD) and mortality. Unlike AKI, accurate estimates of the prevalence, risk factors, and prognosis of AKD have not been thoroughly studied. Methods: From January 2018 to December 2021, a total of 158 patients undergoing CRS-HIPEC were retrospectively reviewed. Patients were separated into non-AKI, AKI, and AKD cohorts. Laboratory parameters and perioperative features were gathered to evaluate risk factors for both HIPEC-induced AKI and AKD, with the 90-day prognosis of AKD patients. Results: AKI developed in 21.5% of patients undergoing CRS-HIPEC, while 13.3% of patients progress to AKD. The multivariate analysis identified that ascites, GRAN%, eGFR, and intraoperative hypotension duration were associated with the development of HIPEC-induced AKI. Higher uric acid, elevated eGFR, and prolonged intraoperative hypotension duration were more predominant in patients proceeding with AKD. The AKD cohort presented a higher risk of 30 days of in-hospital mortality (14.3%) and CKD progression (42.8%).Conclusions: Our study reveals that the incidence of AKI and AKI-to-AKD transition are high. Early identification of risk factors for HIPEC-induced AKD would assist clinicians in taking measures to mitigate the incidence.